End-of-treatment data presented at the EASL Congress from two Phase 2a clinical trials supports advancing imdusiran as a potential cornerstone…
VANCOUVER, BC / ACCESSWIRE / August 1, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical…
NEW YORK, July 31, 2024 /PRNewswire/ -- The global laboratory automation systems market size is estimated to grow by USD…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…
SEATTLE, July 31, 2024 /PRNewswire/ -- TwinStrand Biosciences today announced an agreement with Exact Sciences (Nasdaq: EXAS), a leading provider…
LANDRUM, S.C., July 31, 2024 /PRNewswire/ -- A groundbreaking study conducted by Cambium Analytica, a leader in analytical testing, product…
RANCHO CUCAMONGA, CA / ACCESSWIRE / July 31, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release…
Mr Tulk will spearhead innovative digital solutions, advanced analytics, and new offerings for Vaniam Group's clients. CHICAGO, July 31, 2024 /PRNewswire/…
MasterKey™ enables researchers to customize protein selection from a vast database, selecting 50+ proteins for quantitative multiplex assays.MasterKey™ leverages advanced…